On Monday morning, the FDA gave full approval to the Pfizer COVID-19 vaccine. This is an even faster approval than Pfizer has hoped for, as the most optimistic date had been early September.

Until now, all COVID-19 vaccines have had only EUA-Emergency Use Authorization. Full approval of even one of the available vaccines would immediately bring many important changes to the meaning and role of vaccines throughout the nation.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]